GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » Change In Payables And Accrued Expense

Shelter Pharma (BOM:543963) Change In Payables And Accrued Expense : ₹0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Shelter Pharma Change In Payables And Accrued Expense?

Shelter Pharma's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ₹0.0 Mil. It means Shelter Pharma's Accounts Payable & Accrued Expense stayed the same from Sep. 2023 to Mar. 2024 .

Shelter Pharma's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was ₹0.0 Mil. It means Shelter Pharma's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

Shelter Pharma Change In Payables And Accrued Expense Historical Data

The historical data trend for Shelter Pharma's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shelter Pharma Change In Payables And Accrued Expense Chart

Shelter Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Change In Payables And Accrued Expense
- - - -

Shelter Pharma Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial - - - - -

Shelter Pharma Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shelter Pharma Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Shelter Pharma's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shelter Pharma (BOM:543963) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
NSE:WALPAR BOM:530057 NSE:JFLLIFE BOM:511523 BOM:537253 BOM:542678 BOM:538965 BOM:524703 NSE:VILINBIO BOM:542248 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Mistry Chambers, Khanpur, Ahmedabad, GJ, IND, 380001
Website
https://www.shelter.co.in
Shelter Pharma Ltd focuses in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. It is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. Its products include Tablets, syrups, Baby drops, Barley Water, Oils, Powders, Ointments and Etc.

Shelter Pharma (BOM:543963) Headlines

No Headlines